(Q56592927)

5

0 references

Colin L. Masters

7

object named as

Colin Masters

0 references

Nicola T Lautenschlager

8

object named as

Nicola Lautenschlager

0 references

author name string

Elizabeth A Thomas

1

0 references

J.Gregor Sutcliffe

3

0 references

Clive Harper

4

0 references

Catriona McClean

6

0 references

Samuel E Gandy

9

0 references

Ralph N Martins

Neuropsychiatric symptoms in the dementias

10

0 references

language of work or name

English

0 references

publication date

July 2003

0 references

published in

Biological Psychiatry

0 references

volume

54

0 references

page(s)

136-141

0 references

issue

2

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Altered apolipoprotein D expression in the brain of patients with Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Staging of Alzheimer's disease-related neurofibrillary changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Evolution of Alzheimer's disease related cortical lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Functional and anatomical aspects of prefrontal pathology in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Apolipoprotein D in the aging brain and in Alzheimer's dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Apolipoprotein E polymorphism and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

New frontiers in Alzheimer's disease genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901976-5